iBeta certifies Fujitsu PalmSecure F-Pro for EPCS compliance

Fujitsu has announced that its PalmSecure F-Pro palm vein authentication technology has been certified as compliant with Electronic Prescription for Controlled Substances (EPCS) regulation by iBeta Quality Assurance.

The EPCS regulation is a rule set by the U.S. Drug Enforcement Administration to guide the use of modern technologies by pharmacies, hospitals, and medical practitioners to maintain a closed system of controls on controlled substances.

“We are excited that PalmSecure F-Pro has been rigorously tested and EPCS certified. This will enable Fujitsu to further execute the company strategy of expanding our healthcare portfolio into national chain and independent pharmacies,” says Fujitsu Frontech North America Inc. President Michi Sugawara. “EPCS certification will allow Fujitsu and its partners to expand their ecosystem beyond positive patient identification at hospitals, urgent care and doctor’s offices to now include pharmacies, thereby closing the loop in dispensed controlled substances.”

PalmSecure palm vein sensors capture the vein patterns in users’ hands with near-infrared light without requiring contact. They are not affected by skin conditions, topical lotions, or other factors, and have never failed to register a user, according to Fujitsu.

Medical training company KbPort LLC began offering PalmSecure F-Pro to secure student records earlier this year.

iBeta, which provides independent lab testing for software, recently expanded its biometric testing capabilities to include presentation attack detection (PAD) in accordance with ISO/IEC 30107-3.

Article Topics

biometrics  |  Fujitsu  |  iBeta  |  palm vein authentication